Clinical Trial Update: A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Zabofloxacin 400 mg tablet to Moxifloxacin 400 mg tablet in Chronic Obstructive Pulmonary Disease, assessing efficacy and safety with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Moxifloxacin (moxifloxacin)
• Zabofloxacin (zabofloxacin)

Snippet

Sponsor: Dong Wha Pharmaceutical Co. Ltd. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-09-17